Hint mode is switched on Switch off

Prelude Therapeutics, ordinary share
PRLD, US74065P1012

Add a stock to WL
Choose all Reset all
Prelude Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Prelude Therapeutics Inc operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth.
  • Issuer
  • Full borrower / issuer name
    Prelude Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRLD
  • Placement
    25.09.2020
  • Lock up period
    180
  • Number of papers
    8,325,000
  • Volume of raised funds
    158.18 mln USD
  • Placement share
    19.61%
  • Final placement price
    19 USD
  • Price change since placement date
    -79.79%
  • By capitalization
    806.64 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRLD
  • Placement
    07.01.2021
  • Lock up period
    180
  • Number of papers
    2,500,000
  • Volume of raised funds
    150 mln USD
  • Placement share
    7.18%
  • Final placement price
    60 USD
  • Price change since placement date
    -93.6%
  • By capitalization
    2,088.08 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRLD
  • Placement
    19.05.2023
  • Lock up period
    180
  • Number of papers
    52,412,999
  • Volume of raised funds
    25.86 mln USD
  • Placement share
    8.58%
  • Final placement price
    5.75 USD
  • Price change since placement date
    -33.22%
  • By capitalization
    301.37 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    PRLD
  • Placement
    21.04.2026
  • Lock up period
    180
  • Number of papers
    18,018,014
  • Volume of raised funds
    80 mln USD
  • Placement share
    22.25%
  • Final placement price
    4.44 USD
  • Price change since placement date
    -13.51%
  • By capitalization
    359.51 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

20/04/2026 Prelude Therapeutics: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
20/04/2026 Prelude Therapeutics: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
15/04/2026 Prelude Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
09/01/2026 Prelude Therapeutics: Regulation Fd Disclosure, Financial Statements And Exhibits
03/11/2025 Prelude Therapeutics: Unregistered Sales Of Equity Securities, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.